320 related articles for article (PubMed ID: 33540535)
1. CD44 and Tumor-Derived Extracellular Vesicles (TEVs). Possible Gateway to Cancer Metastasis.
Szatanek R; Baj-Krzyworzeka M
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540535
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived extracellular vesicles in breast cancer: From bench to bedside.
Wang HX; Gires O
Cancer Lett; 2019 Sep; 460():54-64. PubMed ID: 31233837
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan-CD44 interactions as potential targets for cancer therapy.
Misra S; Heldin P; Hascall VC; Karamanos NK; Skandalis SS; Markwald RR; Ghatak S
FEBS J; 2011 May; 278(9):1429-43. PubMed ID: 21362138
[TBL] [Abstract][Full Text] [Related]
4. CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells.
Härkönen K; Oikari S; Kyykallio H; Capra J; Hakkola S; Ketola K; Thanigai Arasu U; Daaboul G; Malloy A; Oliveira C; Jokelainen O; Sironen R; Hartikainen JM; Rilla K
Cells; 2019 Mar; 8(3):. PubMed ID: 30909497
[TBL] [Abstract][Full Text] [Related]
5. The capture of extracellular vesicles endogenously released by xenotransplanted tumours induces an inflammatory reaction in the premetastatic niche.
Blavier L; Nakata R; Neviani P; Sharma K; Shimada H; Benedicto A; Matei I; Lyden D; DeClerck YA
J Extracell Vesicles; 2023 May; 12(5):e12326. PubMed ID: 37194998
[TBL] [Abstract][Full Text] [Related]
6. Molecular Determinants Involved in the Docking and Uptake of Tumor-Derived Extracellular Vesicles: Implications in Cancer.
Clares-Pedrero I; Rocha-Mulero A; Palma-Cobo M; Cardeñes B; Yáñez-Mó M; Cabañas C
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542421
[TBL] [Abstract][Full Text] [Related]
7. CD44‑hyaluronan axis plays a role in the interactions between colon cancer‑derived extracellular vesicles and human monocytes.
Babula A; Gałuszka-Bulaga A; Węglarczyk K; Siedlar M; Baj-Krzyworzeka M
Oncol Lett; 2023 Sep; 26(3):413. PubMed ID: 37600336
[TBL] [Abstract][Full Text] [Related]
8. Lung mechanics modifications facilitating metastasis are mediated in part by breast cancer-derived extracellular vesicles.
Barenholz-Cohen T; Merkher Y; Haj J; Shechter D; Kirchmeier D; Shaked Y; Weihs D
Int J Cancer; 2020 Nov; 147(10):2924-2933. PubMed ID: 32700789
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Derived Extracellular Vesicles and the Immune System-Lessons From Immune-Competent Mouse-Tumor Models.
Droste M; Thakur BK; Eliceiri BP
Front Immunol; 2020; 11():606859. PubMed ID: 33391275
[TBL] [Abstract][Full Text] [Related]
10. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Derived Extracellular Vesicles: Modulation of Cellular Functional Dynamics in Tumor Microenvironment and Its Clinical Implications.
Santos NL; Bustos SO; Bhatt D; Chammas R; Andrade LNS
Front Cell Dev Biol; 2021; 9():737449. PubMed ID: 34532325
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-mediated transfer of cancer-derived components to stromal cells contributes to establishment of a pro-tumor microenvironment.
Umakoshi M; Takahashi S; Itoh G; Kuriyama S; Sasaki Y; Yanagihara K; Yashiro M; Maeda D; Goto A; Tanaka M
Oncogene; 2019 Mar; 38(12):2162-2176. PubMed ID: 30459356
[TBL] [Abstract][Full Text] [Related]
13. Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.
Miwa T; Nagata T; Kojima H; Sekine S; Okumura T
Int J Oncol; 2017 Sep; 51(3):771-780. PubMed ID: 28677740
[TBL] [Abstract][Full Text] [Related]
14. A CD44v
Hu J; Li G; Zhang P; Zhuang X; Hu G
Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
[TBL] [Abstract][Full Text] [Related]
15. Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.
Montero-Montero L; Renart J; Ramírez A; Ramos C; Shamhood M; Jarcovsky R; Quintanilla M; Martín-Villar E
Cells; 2020 Sep; 9(10):. PubMed ID: 33003440
[TBL] [Abstract][Full Text] [Related]
16. Circulating extracellular vesicles derived from tumor endothelial cells hijack the local and systemic anti-tumor immune response: Role of mTOR/G-CSF pathway.
Koni M; Lopatina T; Grange C; Sarcinella A; Cedrino M; Bruno S; Buffolo F; Femminò S; Camussi G; Brizzi MF
Pharmacol Res; 2023 Sep; 195():106871. PubMed ID: 37506784
[TBL] [Abstract][Full Text] [Related]
17. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
18. Tumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapy.
Prakash A; Gates T; Zhao X; Wangmo D; Subramanian S
Pharmacol Ther; 2023 Jan; 241():108332. PubMed ID: 36526013
[TBL] [Abstract][Full Text] [Related]
19. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
[TBL] [Abstract][Full Text] [Related]
20. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis.
Bourrguignon LY; Iida N; Welsh CF; Zhu D; Krongrad A; Pasquale D
J Neurooncol; 1995 Dec; 26(3):201-8. PubMed ID: 8750186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
